
Heidi Ledford
Science Reporter at Nature
Science reporter @nature mostly covering biomedicine. Views my own. She/her. PhD.
Articles
-
1 week ago |
scientificamerican.com | Heidi Ledford |Rachel Fieldhouse
An emergency-room doctor, critics of COVID-19 vaccines and an obstetrician who advises a supplement company are among the advisers handpicked by vaccine sceptic Robert F. Kennedy Jr, the head of the US Department of Health and Human Services (HHS), to provide advice on vaccines to the federal government.
-
2 weeks ago |
nature.com | Heidi Ledford |Rachel Fieldhouse
An emergency-room doctor, critics of COVID-19 vaccines and an obstetrician who advises a supplement company are among the advisers handpicked by vaccine skeptic Robert F. Kennedy Jr, the head of the US Department of Health and Human Services (HHS), to provide advice on vaccines to the federal government.
-
1 month ago |
nature.com | Heidi Ledford
The CRISPR family’s most versatile member has made its medical debut: a cutting-edge gene-editing technique known as prime editing has been used to treat a person for the first time. The recipient is a teenager with a rare immune disorder. Researchers designed the treatment to correct some of the mutations that cause chronic granulomatous disease, a dangerous condition that disables a variety of immune cells, including those called neutrophils.
-
1 month ago |
scientificamerican.com | Heidi Ledford
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation. Little KJ Muldoon, now nearly ten months old, is doing well after receiving three doses of a gene-editing treatment to mend a mutation that impaired his body’s ability to process protein, his parents told reporters this week.
-
1 month ago |
nature.com | Heidi Ledford
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation1. Little KJ Muldoon, now nearly ten months old, is doing well after receiving three doses of a gene-editing treatment to mend a mutation that had impaired his body’s ability to process protein, his parents told reporters this week.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 5
- DMs Open
- No

RT @NickDesnoyer: Freaky Flowers Volume 3!🌸🧬 Did you know that just a few mutations can transform the Arabidopsis flower into all kinds…

RT @NYTScience: Despite all my rage I am still just a crab in a maze https://t.co/9VWKxgAE9P

RT @Mammals_Suck: I'm just saying, getting published in Nature used to be way easier. https://t.co/r8M6k3QSaU